1. Home
  2. AURA vs HUYA Comparison

AURA vs HUYA Comparison

Compare AURA & HUYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$6.30

Market Cap

631.6M

Sector

Health Care

ML Signal

HOLD

Logo HUYA Inc. American depositary shares each  representing one ordinary share

HUYA

HUYA Inc. American depositary shares each representing one ordinary share

HOLD

Current Price

$2.21

Market Cap

572.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AURA
HUYA
Founded
2007
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
631.6M
572.2M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
AURA
HUYA
Price
$6.30
$2.21
Analyst Decision
Strong Buy
Buy
Analyst Count
6
11
Target Price
★ $16.60
$3.52
AVG Volume (30 Days)
★ 869.6K
617.9K
Earning Date
11-12-2026
11-11-2026
Dividend Yield
N/A
★ 6.05%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.15
Revenue Next Year
N/A
$7.09
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.73
$2.02
52 Week High
$9.54
$4.93

Technical Indicators

Market Signals
Indicator
AURA
HUYA
Relative Strength Index (RSI) 45.48 45.55
Support Level $6.04 $2.15
Resistance Level $7.18 $2.55
Average True Range (ATR) 0.28 0.06
MACD 0.05 -0.01
Stochastic Oscillator 30.66 10.00

Price Performance

Historical Comparison
AURA
HUYA

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About HUYA HUYA Inc. American depositary shares each representing one ordinary share

Huya officially became independent in 2016 and is headquartered in Guangzhou. It operates a live streaming platform focused on games, esports, and interactive entertainment, and also provides game-related services such as distribution and in-game item sales. Its main livestreaming platforms include Huya Live in China and Nimo TV outside of China. Huya is a subsidiary of Tencent, which owned 67% of its equity stake and held 95% of the voting power, as of the end of 2025.

Share on Social Networks: